天堂国产午夜亚洲专区-少妇人妻综合久久蜜臀-国产成人户外露出视频在线-国产91传媒一区二区三区

當(dāng)前位置:主頁 > 醫(yī)學(xué)論文 > 心血管論文 >

優(yōu)化對比劑注射方案對冠狀動脈CTA圖像的影響

發(fā)布時間:2018-03-01 03:00

  本文關(guān)鍵詞: 冠狀動脈 對比劑 注射方法 圖像質(zhì)量 出處:《臨床放射學(xué)雜志》2017年11期  論文類型:期刊論文


【摘要】:目的探討冠狀動脈CTA時不同對比劑注射方案對圖像質(zhì)量的影響,優(yōu)化注射方案。方法選取體重指數(shù)相似患者320例,分為A、B、C、D四組,進(jìn)行冠狀動脈CTA。A組對比劑采用雙相注射方案,先期注射對比劑70 ml,而后注射生理鹽水20 ml;B組采用雙相注射方案,先期注射對比劑50 ml,而后注射混合液(生理鹽水-對比劑1∶1)20 ml,C組采用三相注射方案,先期注射對比劑50 ml,第二時相注射混合液(生理鹽水-對比劑1∶1)20 ml,而后無縫隙注射生理鹽水20 ml;D組采用雙相注射方案,先期注射對比劑50 ml,而后注射混合液(生理鹽水-對比劑1∶1)20 ml,掃描時間較常規(guī)延遲5 s。比較四組冠狀動脈CTA圖像中冠狀動脈三大分支和升主動脈(AO)CT值之間有無差異,比較四組上腔靜脈、右心室硬化偽影發(fā)生率及室間隔顯示率。結(jié)果與A組比較,B、C兩組對比劑雖減少10 ml,但三組間AO及冠狀動脈三大分支CT值比較無統(tǒng)計學(xué)意義(P0.05),而D組CT值較A、B、C三組降低(P0.05);B組上腔靜脈、右心室硬化偽影發(fā)生率高于A、C、D三組(P0.05),C、D兩組室間隔顯示率無統(tǒng)計學(xué)差異(P0.05),但高于A、B兩組(P0.05)。結(jié)論采用三時相對比劑注射方案,可以有效降低對比劑用量,保證圖像質(zhì)量,清晰顯示室間隔,為冠狀動脈疾病的診斷提供影像依據(jù)。
[Abstract]:Objective to investigate the effect of different contrast media injection on image quality in coronary artery CTA and optimize the injection protocol. Methods 320 patients with similar body mass index were divided into four groups. The coronary artery CTA.A group was treated with biphasic injection. Group B was treated with biphasic injection, group B with 20 ml saline, and group B with 50 ml of contrast agent, and then with a mixture of saline and contrast agent (1: 1 1: 20 ml / C). First, 50 ml contrast agent was injected, the second phase was injected with mixed solution (1: 1 1: 20 ml of saline), and then the group D was given biphasic injection of 20 ml saline without slit injection. 50 ml contrast agent was injected first, and then mixed solution (1: 1ml contrast agent) was injected. The scanning time was delayed by 5 s. The differences between the three branches of coronary artery and ascending aorta in CTA images of four groups were compared. The superior vena cava was compared among the four groups. Results compared with group A, the incidence of right ventricular sclerosis artifact and the rate of ventricular septal display were decreased by 10 ml, but the CT values of AO and coronary artery branches in group D were not significantly higher than those in group A (P 0.05), but the CT value in group D was higher than that in group A (P < 0.05). The superior vena cava was decreased in group B. The incidence of right ventricular sclerosis artifact was higher than that of the three groups (P 0.05 and P 0.05), but it was higher than that of group A B (P 0.05). Conclusion the dosage of contrast agent can be reduced effectively and the image quality can be ensured by using the three-time contrast agent injection regimen, and the results are as follows: (1) the incidence of right ventricular sclerosis artifact is higher than that of the control group (P 0.05), but it is higher than that of group A B (P 0.05). The clear display of ventricular septum provides imaging basis for the diagnosis of coronary artery disease.
【作者單位】: 華北理工大學(xué)附屬醫(yī)院CT室;華北理工大學(xué)基礎(chǔ)醫(yī)學(xué)院病理教研室;
【分類號】:R541.4;R816.2

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 張輝陽;周智鵬;邱維加;凌秀梅;蘇壽紅;曾陽東;;根據(jù)體重對比劑注射方案在64層螺旋CT冠狀動脈成像中的應(yīng)用[J];華夏醫(yī)學(xué);2011年02期

2 黃偉;王峻;暴潔;唐笑先;趙麗莎;;稀釋對比劑注射法在64層螺旋CT左心室功能評估中的應(yīng)用研究[J];實用醫(yī)學(xué)影像雜志;2011年04期

3 黎雪琴;羅紅亮;劉文婷;;64排螺旋CT冠狀動脈成像時不同對比劑注射方案的特點[J];中國中西醫(yī)結(jié)合影像學(xué)雜志;2012年02期

4 徐霞;武志峰;鄂林寧;張玉;王剛;張騰威;胥曼;;多排螺旋CT直接法上腔靜脈成像方法研究[J];基層醫(yī)學(xué)論壇;2013年35期

5 季立標(biāo);曹文洪;馬明華;;按體質(zhì)量分組固定時長對比劑注射方案在CT冠狀動脈成像中的應(yīng)用[J];實用醫(yī)學(xué)影像雜志;2012年05期

6 崔晨;劉建新;王霄英;楊俊哲;郭小超;;三期團(tuán)注法對比劑注射方案在肺動脈CTA檢查中的應(yīng)用研究[J];放射學(xué)實踐;2013年05期

7 曹希明;黃美萍;鄭君惠;巫梓斌;溫孟皇;;個體化對比劑注射方案在256層CT冠狀動脈成像中的應(yīng)用[J];醫(yī)學(xué)影像學(xué)雜志;2012年05期

8 宋會軍;王宏宇;侯志輝;吳言伶;韓磊;呂濱;;房間隔缺損患者行冠狀動脈CTA檢查的個性化對比劑注射方案研究[J];放射學(xué)實踐;2012年11期

9 馬春梅;宮鳳玲;陳偉彬;張惠英;;256層CT冠狀動脈成像中優(yōu)化對比劑注射技術(shù)對圖像質(zhì)量的影響[J];中國煤炭工業(yè)醫(yī)學(xué)雜志;2013年02期

10 姜原;劉建新;王霄英;邱建星;;冠脈CT檢查個體化對比劑注射方案的優(yōu)化研究[J];放射學(xué)實踐;2013年03期

,

本文編號:1550077

資料下載
論文發(fā)表

本文鏈接:http://sikaile.net/yixuelunwen/xxg/1550077.html


Copyright(c)文論論文網(wǎng)All Rights Reserved | 網(wǎng)站地圖 |

版權(quán)申明:資料由用戶77546***提供,本站僅收錄摘要或目錄,作者需要刪除請E-mail郵箱bigeng88@qq.com